PMGC HOLDINGS INC. Additional Paid in Capital, Common Stock
PMGC HOLDINGS INC. (ELAB) had Additional Paid in Capital, Common Stock of $19.93 million as of 2024-12-31, per its 10-K filed 2025-03-28.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent › Additional Paid in Capital
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2025-03-28
- 2024-12-31: Additional Paid in Capital, Common Stock $19.93M.
- 2024-09-30: Additional Paid in Capital, Common Stock $19.88M.
- 2024-06-30: Additional Paid in Capital, Common Stock $12.47M.
- 2024-03-31: Additional Paid in Capital, Common Stock $10.90M.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2024-12-31 | $19.93M 10-K · filed 2025-03-28 | |
| 2024-09-30 | $19.88M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $12.47M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $10.90M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $10.85M 10-K · filed 2025-03-28 | $10.85M 10-Q · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |